+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 63 Pages
  • April 2023
  • GlobalData
  • Novozymes Inc
  • ID: 1495434
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Novozymes AS (Novozymes) is a biotechnology company, which produces and sells industrial enzymes and microorganisms. The company provides enzymes for detergents, and technical, food, and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning, and wastewater treatment; and bio innovation solutions to minimize CO2 emissions. Novozymes’s products also find application in hand and automatic dishwashing soaps, laundry detergents, and professional cleaning products. It conducts R&D, production, sale, and marketing operations through its subsidiaries. The company has an operational presence spanning Europe, the Middle East, Africa, North America, Asia-Pacific, and Latin America. Novozymes is headquartered in Bagsvaerd, Denmark.

Novozymes AS Key Recent Developments

  • Mar 30, 2023: Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner
  • Mar 02, 2023: Novozymes Announces Resolutions of Annual Shareholders’ Meeting 2023
  • Feb 03, 2023: Novozymes' Invitation to annual shareholders' meeting 2023
  • Jan 26, 2023: Novozymes delivers historically strong full-year results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Novozymes AS - Key Facts
  • Novozymes AS - Key Employees
  • Novozymes AS - Key Employee Biographies
  • Novozymes AS - Major Products and Services
  • Novozymes AS - History
  • Novozymes AS - Company Statement
  • Novozymes AS - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Novozymes AS - Business Description
  • Business Segment: Agriculture and Animal Health
  • Overview
  • Performance
  • Business Segment: Bioenergy
  • Overview
  • Performance
  • Business Segment: Food, Beverages and Human Health
  • Overview
  • Performance
  • Business Segment: Grain and Tech Processing
  • Overview
  • Performance
  • Business Segment: Household Care
  • Overview
  • Performance
  • Geographical Segment: Asia-Pacific
  • Performance
  • Geographical Segment: Denmark
  • Performance
  • Geographical Segment: Latin America
  • Performance
  • Geographical Segment: North America
  • Performance
  • Geographical Segment: Rest of Europe, Middle-East and Africa
  • Performance
  • R&D Overview
  • Novozymes AS - Corporate Strategy
  • Novozymes AS - SWOT Analysis
  • SWOT Analysis - Overview
  • Novozymes AS - Strengths
  • Novozymes AS - Weaknesses
  • Novozymes AS - Opportunities
  • Novozymes AS - Threats
  • Novozymes AS - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences, Power Financial Deals and Alliances
  • Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Novozymes AS, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Novozymes AS, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 30, 2023: Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner
  • Mar 02, 2023: Novozymes Announces Resolutions of Annual Shareholders’ Meeting 2023
  • Feb 03, 2023: Novozymes' Invitation to annual shareholders' meeting 2023
  • Jan 26, 2023: Novozymes delivers historically strong full-year results
  • Jan 26, 2023: Novozymes Announces financial statement and annual report for 2022
  • Dec 12, 2022: Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner
  • Nov 03, 2022: Novozymes Interim report for the first nine months of 2022
  • Aug 11, 2022: Novozymes delivers strong half year results and narrows full-year outlook upwards
  • Aug 11, 2022: Novozymes Announces Interim report for 1H 2022
  • Apr 26, 2022: Novozymes Interim report for Q1 2022
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Novozymes AS, Key Facts
  • Novozymes AS, Key Employees
  • Novozymes AS, Key Employee Biographies
  • Novozymes AS, Major Products and Services
  • Novozymes AS, History
  • Novozymes AS, Subsidiaries
  • Novozymes AS, Key Competitors
  • Novozymes AS, Ratios based on current share price
  • Novozymes AS, Annual Ratios
  • Novozymes AS, Interim Ratios
  • Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Novozymes AS, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Novozymes AS, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Novozymes AS, Performance Chart (2018 - 2022)
  • Novozymes AS, Ratio Charts
  • Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Novozymes AS, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Royal DSM NV
  • Lonza Group Ltd
  • FMC Corp
  • Codexis Inc
  • Biocon Ltd
  • BASF SE
  • AB Enzymes GmbH
  • DuPont de Nemours Inc
  • Codexis Inc
  • Biocon Ltd
  • Royal DSM NV
  • AB Enzymes GmbH
  • BASF SE